To investigate the effect of SPATS2 on the tumorigenic capacity of HCC cells in vivo, xenograft tumor growth assay was established by subcutaneous transplantation with either HCC-LM3- PLKO.1 or HCC-LM3-shSPATS2 cells into nude mice. The gene discussed is SPATS2; the disease is hepatocellular carcinoma.